In osteosarcoma patients, tumor overexpression of the VEGF protein has been associated with poor prognosis [13,14], and the amplification of the VEGF or VEGFR2 coding genes has also been reported in these patients [14,15,16]. This evidence concerns the gene VEGFA and neoplasm.